Postmarket Surveillance Issues for Medical Devices
Track
:
Track 09: Medical Devices, In Vitro Diagnostics, and Combination Products
Program Code:
213
Date:
Tuesday, June 25, 2013
Time:
8:00 AM to 9:30 AM
EST
Location:
253C
CHAIR
:
Kirsten H. Paulson, (SCHSUP), Senior Officer, Medical Device Initiative, The Pew Charitable Trusts, United States
Kirsten Paulson is the Senior Officer, Medical Device Initiative of The Pew Charitable Trusts. Previously, she was , RA of the PPD Medical Device and Diagnostics group. She began her career as an FDA reviewer. Kirsten has a BS from Boston University and an MS in Bioengineering from Penn State.
SPEAKER
(S):
Colin R.W. Hayward, FFPM (SPKNON), Vice President, Medical Affairs, Premier Research Group, United Kingdom
Colin is a Fellow of the Faculty of Pharmaceutical Medicine with 13 yrs Internat'l experience in safety, design and implementation of clinical programs & med affairs. He started his career in industry with Roche. He is responsible for leading the Premier Research's Global Med Affairs & PV teams.
Kirsten H. Paulson, (SPKSUP), Senior Officer, Medical Device Initiative, The Pew Charitable Trusts, United States
Kirsten Paulson is the Senior Officer, Medical Device Initiative of The Pew Charitable Trusts. Previously, she was , RA of the PPD Medical Device and Diagnostics group. She began her career as an FDA reviewer. Kirsten has a BS from Boston University and an MS in Bioengineering from Penn State.
Description
FDA's CDRH released a draft National Postmarket Strategy in September 2012, outlining major areas of focus for the postmarket program. This session will look at the scope of the strategy document and status, provide an overview of the Postapproval Study program and look in detail at one of the pillars of the new strategy — medical device registries.